![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-desktop-headergif-72716.gif)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-mob-headergif-95876.gif)
API Suppliers
US DMFs Filed
0
CEP/COS Certifications
0
JDMFs Filed
0
EU WC
0
Listed Suppliers
0
0
USA (Orange Book)
Europe
Canada
Australia
South Africa
Uploaded Dossiers
0
U.S. Medicaid
Annual Reports
0
https://www.fiercepharma.com/fierce-biotech/esmo-amgen-sticks-lumakras-high-dose-touts-new-colorectal-cancer-data
https://www.prnewswire.com/news-releases/lumakras-sotorasib-combined-with-vectibix-panitumumab-shows-confirmed-30-objective-response-rate-in-patients-with-kras-g12c-mutated-metastatic-colorectal-cancer-301621681.html
https://www.reuters.com/business/healthcare-pharmaceuticals/cancer-research-amgen-drug-extends-survival-some-inoperable-colon-cancers-2022-06-05/
https://www.prnewswire.com/news-releases/lumakras-sotorasib-combined-with-vectibix-panitumumab-showed-encouraging-efficacy-and-safety-in-patients-with-kras-g12c-mutated-colorectal-cancer-301378188.html
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=125147
https://www.prnewswire.com/news-releases/cross-industry-collaboration-of-gns-healthcare-amgen-and-alliance-for-clinical-trials-in-oncology-to-leverage-ai-to-advance-understanding-of-treatment-response-in-metastatic-colorectal-cancer-300707652.html